dalteparin has been researched along with Angiogenesis, Pathologic in 16 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion with that of aspirin." | 9.13 | Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. ( Farahvash, MM; Farahvash, MS; Mohammadzadeh, S; Moradimogadam, M, 2008) |
| "To compare the long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion with that of aspirin." | 5.13 | Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. ( Farahvash, MM; Farahvash, MS; Mohammadzadeh, S; Moradimogadam, M, 2008) |
| " A dose-response effect was not identified." | 2.77 | Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study. ( Elit, LM; Hoskins, P; Julian, DH; Julian, JA; Lee, AY; Levine, MN; Liaw, PC; Parpia, S; Swystun, LL, 2012) |
| "Advanced pancreatic cancer, in addition to its high mortality, is characterized by one of the highest rates of venous thromboembolic events (VTE) as compared to other types of cancer." | 2.73 | Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). ( Bramlage, P; Dörken, B; Hilbig, A; Kauschat-Brüning, D; Oettle, H; Opitz, B; Pelzer, U; Riess, H; Scholten, T; Stieler, J, 2008) |
| "An association between cancer and thrombosis has been recognized since 1865." | 2.46 | Bemiparin in oncology. ( Lecumberri Villamediana, R; Monreal Bosch, M; Prandoni, P; Vignoli, A, 2010) |
| "HT29 human colorectal cancers were implanted in dorsal skinfold window chambers in athymic mice." | 1.42 | Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study. ( Ceelen, W; Debergh, I; Pattyn, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debergh, I | 2 |
| Pattyn, P | 2 |
| Ceelen, W | 1 |
| Van Damme, N | 1 |
| Peeters, M | 1 |
| Ceelen, WP | 1 |
| Monreal Bosch, M | 1 |
| Vignoli, A | 2 |
| Lecumberri Villamediana, R | 1 |
| Prandoni, P | 1 |
| Marchetti, M | 1 |
| Russo, L | 1 |
| Cantalino, E | 1 |
| Diani, E | 1 |
| Bonacina, G | 1 |
| Falanga, A | 1 |
| Naumnik, B | 1 |
| Koc-Żórawska, E | 1 |
| Myśliwiec, M | 1 |
| Riess, H | 1 |
| Pelzer, U | 1 |
| Hilbig, A | 1 |
| Stieler, J | 1 |
| Opitz, B | 1 |
| Scholten, T | 1 |
| Kauschat-Brüning, D | 1 |
| Bramlage, P | 1 |
| Dörken, B | 1 |
| Oettle, H | 1 |
| Boztosun, A | 1 |
| Piçnak, A | 1 |
| Kosar, MI | 1 |
| Gulturk, S | 1 |
| Cetin, A | 1 |
| Rui, Y | 1 |
| Wang, D | 1 |
| Hu, D | 1 |
| Huang, L | 1 |
| Farahvash, MS | 1 |
| Farahvash, MM | 1 |
| Moradimogadam, M | 1 |
| Mohammadzadeh, S | 1 |
| Nakamura, S | 2 |
| Kanatani, Y | 1 |
| Kishimoto, S | 1 |
| Ohno, C | 1 |
| Horio, T | 1 |
| Masanori, F | 1 |
| Hattori, H | 1 |
| Tanaka, Y | 1 |
| Kiyosawa, T | 1 |
| Maehara, T | 1 |
| Ishihara, M | 1 |
| Elit, LM | 1 |
| Lee, AY | 1 |
| Parpia, S | 1 |
| Swystun, LL | 1 |
| Liaw, PC | 1 |
| Hoskins, P | 1 |
| Julian, DH | 1 |
| Julian, JA | 1 |
| Levine, MN | 1 |
| Caine, GJ | 1 |
| Harris, AL | 1 |
| Christodoulos, K | 1 |
| Lip, GY | 1 |
| Blann, AD | 1 |
| Takahashi, H | 1 |
| Ebihara, S | 1 |
| Okazaki, T | 1 |
| Asada, M | 1 |
| Sasaki, H | 1 |
| Yamaya, M | 1 |
| Sudha, T | 1 |
| Yalcin, M | 1 |
| Lin, HY | 1 |
| Elmetwally, AM | 1 |
| Nazeer, T | 1 |
| Arumugam, T | 1 |
| Phillips, P | 1 |
| Mousa, SA | 2 |
| Bauer, AT | 1 |
| Suckau, J | 1 |
| Frank, K | 1 |
| Desch, A | 1 |
| Goertz, L | 1 |
| Wagner, AH | 1 |
| Hecker, M | 1 |
| Goerge, T | 1 |
| Umansky, L | 1 |
| Beckhove, P | 1 |
| Utikal, J | 1 |
| Gorzelanny, C | 1 |
| Diaz-Valdes, N | 1 |
| Umansky, V | 1 |
| Schneider, SW | 1 |
| Mohamed, S | 1 |
1 review available for dalteparin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Bemiparin in oncology.
Topics: Anticoagulants; Antineoplastic Agents; Chemotherapy, Adjuvant; Fibrinolytic Agents; Heparin, Low-Mol | 2010 |
4 trials available for dalteparin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Appointments and Schedules; Atherosclerosis; Chemoki | 2013 |
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).
Topics: Adolescent; Adult; Animals; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Cisplati | 2008 |
Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion.
Topics: Aspirin; Dalteparin; Female; Fibrinolytic Agents; Humans; Iris; Male; Middle Aged; Neovascularizatio | 2008 |
Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bridged-Ring Compoun | 2012 |
11 other studies available for dalteparin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study.
Topics: Adenocarcinoma; Animals; Anticoagulants; Colorectal Neoplasms; Enoxaparin; HT29 Cells; Humans; Immun | 2015 |
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.
Topics: Animals; Anticoagulants; Blood Flow Velocity; Cricetinae; Erythrocytes; Immunoenzyme Techniques; Mel | 2010 |
LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Cell Line, Tumor; Endothelial Cells; Female; Fibroblast G | 2011 |
Effects of methylene blue, pentoxyphylline and enoxaparin on postoperative adhesion formation and markers of angiogenesis in a rat uterine horn model.
Topics: Animals; Enoxaparin; Enzyme Inhibitors; Female; Fibrinolytic Agents; Free Radical Scavengers; Immuno | 2012 |
Role of dalteparin sodium on the growth of cancer cells and tumor-associated angiogenesis in A549 human lung cancer cell line and grafted mouse model.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cisplatin; | 2018 |
Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
Topics: Animals; Biodegradation, Environmental; Dalteparin; Diffusion; Dose-Response Relationship, Drug; Dru | 2009 |
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxa | 2005 |
A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
Topics: Animals; Anticoagulants; Bleeding Time; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chondro | 2005 |
Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Deoxycyt | 2014 |
von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Blood Coagulation; Blood Platelets; Disease Models, Animal | 2015 |
Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Chick Embryo; Chorioallantoic Membrane; Co | 2004 |